Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
974.5 INR | -0.78% | -2.41% | +41.23% |
02:02am | Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets | MT |
10/05 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.23% | 11.83B | |
+19.70% | 43.27B | |
+24.69% | 22.92B | |
+20.29% | 15.43B | |
+12.89% | 12.95B | |
-8.43% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Forms UAE-Based Arm